NO911065L - Fremgangsmaate for fremstilling av lipopeptidderivater. - Google Patents

Fremgangsmaate for fremstilling av lipopeptidderivater.

Info

Publication number
NO911065L
NO911065L NO91911065A NO911065A NO911065L NO 911065 L NO911065 L NO 911065L NO 91911065 A NO91911065 A NO 91911065A NO 911065 A NO911065 A NO 911065A NO 911065 L NO911065 L NO 911065L
Authority
NO
Norway
Prior art keywords
procedure
preparation
lipopeptide derivatives
lipopeptide
derivatives
Prior art date
Application number
NO91911065A
Other languages
English (en)
Other versions
NO911065D0 (no
Inventor
Milton L Hammond
James M Balkovec
Robert E Schwartz
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO911065D0 publication Critical patent/NO911065D0/no
Publication of NO911065L publication Critical patent/NO911065L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO91911065A 1990-03-19 1991-03-18 Fremgangsmaate for fremstilling av lipopeptidderivater. NO911065L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49519990A 1990-03-19 1990-03-19

Publications (2)

Publication Number Publication Date
NO911065D0 NO911065D0 (no) 1991-03-18
NO911065L true NO911065L (no) 1991-09-20

Family

ID=23967674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911065A NO911065L (no) 1990-03-19 1991-03-18 Fremgangsmaate for fremstilling av lipopeptidderivater.

Country Status (11)

Country Link
EP (1) EP0448343A3 (no)
JP (1) JPH07121957B2 (no)
KR (1) KR910016771A (no)
AU (1) AU7358591A (no)
CA (1) CA2038497A1 (no)
FI (1) FI911308A (no)
IE (1) IE910893A1 (no)
IL (1) IL97347A0 (no)
NO (1) NO911065L (no)
PT (1) PT97043A (no)
ZA (1) ZA911978B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
IL122315A (en) * 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
DE69419544T2 (de) * 1993-02-23 1999-11-25 Hitachi Ltd Wirbelstromgebläse und Schaufelrad
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (en) 1998-08-20 2005-01-26 Eli Lilly & Company Synthesis of ring-modified cyclic peptide analogs
AU772633B2 (en) 1999-03-03 2004-05-06 Eli Lilly And Company Echinocandin/carbohydrate complexes
ES2433678T3 (es) 1999-03-03 2013-12-12 Eli Lilly & Company Formulaciones farmacéuticas de equinocandina que contienen tensioactivos formadores de micelas
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030844A1 (en) * 1979-12-13 1981-06-24 Eli Lilly And Company Recovery process for A-30912 antibiotics

Also Published As

Publication number Publication date
IE910893A1 (en) 1991-09-25
AU7358591A (en) 1993-01-28
CA2038497A1 (en) 1991-09-20
IL97347A0 (en) 1992-05-25
EP0448343A2 (en) 1991-09-25
ZA911978B (en) 1991-12-24
JPH07121957B2 (ja) 1995-12-25
FI911308A (fi) 1991-09-20
EP0448343A3 (en) 1992-01-22
KR910016771A (ko) 1991-11-05
PT97043A (pt) 1991-10-31
FI911308A0 (fi) 1991-03-18
JPH04217699A (ja) 1992-08-07
NO911065D0 (no) 1991-03-18

Similar Documents

Publication Publication Date Title
NO913234D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO911591L (no) Fremgangsmaate for fremstilling av sukrose-6-ester.
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO912346L (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO911122D0 (no) Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler.
NO913008D0 (no) Fremgangsmaate for fremstilling av fenylacetamid-derivater.
NO911065D0 (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
NO911606L (no) Fremgangsmaate for fremstilling av glycidylazidpolymer.
NO903431L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO905377D0 (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO905444L (no) Fremgangsmaate til fremstilling av oksazolderivater.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO914053D0 (no) Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO914985L (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO911672D0 (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO912979L (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenederivater.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO914452D0 (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO913429D0 (no) Fremgangsmaate for fremstilling av 5-benzyl-substituerte benzimidazolin-2-tion-derivater.
NO904362L (no) Fremgangsmaate for fremstilling av kromanderivater.